Cite
Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease
MLA
Péter Kustán, et al. “Elevated Urinary Orosomucoid Excretion as a Novel Biomarker in Crohn’s Disease.” European Journal of Clinical Investigation, vol. 49, no. 3, May 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19d45b341bf275345fc908c1326b040d&authtype=sso&custid=ns315887.
APA
Péter Kustán, Zoltán Horváth-Szalai, Balázs Szirmay, András Tárnok, Attila Miseta, Nóra Szigeti, Tamás Kőszegi, Andrea Ludány, & Patrícia Sarlós. (2018). Elevated urinary orosomucoid excretion as a novel biomarker in Crohn’s disease. European Journal of Clinical Investigation, 49(3).
Chicago
Péter Kustán, Zoltán Horváth-Szalai, Balázs Szirmay, András Tárnok, Attila Miseta, Nóra Szigeti, Tamás Kőszegi, Andrea Ludány, and Patrícia Sarlós. 2018. “Elevated Urinary Orosomucoid Excretion as a Novel Biomarker in Crohn’s Disease.” European Journal of Clinical Investigation 49 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....19d45b341bf275345fc908c1326b040d&authtype=sso&custid=ns315887.